{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:25:15Z","timestamp":1766111115870,"version":"3.48.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK119463"],"award-info":[{"award-number":["K23DK119463"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jpeds.2023.01.025","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T21:17:59Z","timestamp":1677791879000},"page":"113372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical Course Associated with Aseptic Meningitis Induced by Intravenous Immunoglobulin for the Treatment of Multisystem Inflammatory Syndrome in Children"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7323-4834","authenticated-orcid":false,"given":"Cameron C.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri L.","family":"LaRovere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Newhams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suden","family":"Kucukak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira J.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline B.","family":"Maddux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha B.","family":"Halasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Irby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne G.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela P.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-2862","authenticated-orcid":false,"given":"Mary Beth F.","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2023.01.025_bib1","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2023.01.025_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2023.01.025_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000268855","article-title":"Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines","volume":"123","author":"De Mattia","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib5","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1080\/21645515.2015.1061161","article-title":"The usefulness of immunotherapy in pediatric neurodegenerative disorders: a systematic review of literature data","volume":"11","author":"Vitaliti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpeds.2023.01.025_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaci.2008.08.033","article-title":"Intravenous immunoglobulin: adverse reactions and management","volume":"122","author":"Bonilla","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","article-title":"Adverse effects of human immunoglobulin therapy","volume":"27","author":"Stiehm","year":"2013","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jpeds.2023.01.025_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-9-28","article-title":"Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease","volume":"9","author":"Kemmotsu","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jpeds.2023.01.025_bib11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00006454-199811000-00023","article-title":"Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome","volume":"17","author":"Boyce","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2023.01.025_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00043426-199911000-00012","article-title":"Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura","volume":"21","author":"Jayabose","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00006565-200212000-00006","article-title":"Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid","volume":"18","author":"Obando","year":"2002","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jpeds.2023.01.025_bib14","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/jcm11133571","article-title":"Intravenous immunoglobulin-induced aseptic meningitis-A narrative review of the diagnostic process, pathogenesis, preventative measures and treatment","volume":"11","author":"Kretowska-Grunwald","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpeds.2023.01.025_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/1817-1745.92858","article-title":"Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency","volume":"6","author":"Kaarthigeyan","year":"2011","journal-title":"J Pediatr Neurosci"},{"key":"10.1016\/j.jpeds.2023.01.025_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neurol.2019.07.005","article-title":"Aseptic meningitis","volume":"175","author":"Tattevin","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jpeds.2023.01.025_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","article-title":"Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome","volume":"78","author":"LaRovere","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaneurol.2022.3881","article-title":"Changes in distribution of severe neurologic involvement in US pediatric inpatients with COVID-19 or multisystem inflammatory syndrome in children in 2021 vs 2020","volume":"80","author":"LaRovere","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jpeds.2023.01.025_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2023.01.025_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"year":"2017","series-title":"Electronic Code of Federal Regulations Part 46 \u2013 Protection of Human Subjects","key":"10.1016\/j.jpeds.2023.01.025_bib21"},{"key":"10.1016\/j.jpeds.2023.01.025_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"year":"2020","series-title":"Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus 9 disease 2019 (COVID-19)","key":"10.1016\/j.jpeds.2023.01.025_bib23"},{"key":"10.1016\/j.jpeds.2023.01.025_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/clinchem\/46.3.399","article-title":"Cerebrospinal fluid protein concentrations in children: age-related values in patients without disorders of the central nervous system","volume":"46","author":"Biou","year":"2000","journal-title":"Clin Chem"},{"year":"2015","series-title":"Package Insert - GAMUNEX-C","key":"10.1016\/j.jpeds.2023.01.025_bib25"},{"year":"2012","series-title":"Package Insert \u2013 Gammagard","key":"10.1016\/j.jpeds.2023.01.025_bib26"},{"key":"10.1016\/j.jpeds.2023.01.025_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.autrev.2006.08.011","article-title":"Safety of intravenous immunoglobulin (IVIG) therapy","volume":"6","author":"Katz","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jpeds.2023.01.025_bib28","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/trf.13200","article-title":"Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center","volume":"55","author":"Bharath","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jpeds.2023.01.025_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpeds.2023.01.025_bib30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1345\/aph.1K198","article-title":"Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid","volume":"41","author":"Gurcan","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpeds.2023.01.025_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children - initial therapy and outcomes","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623001300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623001300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:11:33Z","timestamp":1766110293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347623001300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"alternative-id":["S0022347623001300"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.01.025","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Course Associated with Aseptic Meningitis Induced by Intravenous Immunoglobulin for the Treatment of Multisystem Inflammatory Syndrome in Children","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113372"}}